westvirginiadigitalnews.com
Advertisement
  • Home
  • News
    • PRESS RELEASE
  • Shop
  • BUSINESS
    • CRYPTO
    • ECONOMY
    • FINANCE
    • MARKET
    • MONEY
  • TECH
    • APPS
    • GADGET
    • MOBILE
    • SCIENCE
  • SOCIAL MEDIA
  • ENTERTAINMENT
    • ARTS & THEATER
    • GAMING
    • GAMBLING
    • MOVIE
    • MUSIC
    • SHOWS
    • SPORTS
  • LIFESTYLE
    • CELEBRITY
    • CULTURE
    • Education
    • FASHION
    • FOOD
    • HEALTH
    • HISTORY
    • Nature
    • Religion
    • Shopping
    • TRAVEL
  • REAL ESTATE
  • Blog
  • Classifieds
No Result
View All Result
  • Home
  • News
    • PRESS RELEASE
  • Shop
  • BUSINESS
    • CRYPTO
    • ECONOMY
    • FINANCE
    • MARKET
    • MONEY
  • TECH
    • APPS
    • GADGET
    • MOBILE
    • SCIENCE
  • SOCIAL MEDIA
  • ENTERTAINMENT
    • ARTS & THEATER
    • GAMING
    • GAMBLING
    • MOVIE
    • MUSIC
    • SHOWS
    • SPORTS
  • LIFESTYLE
    • CELEBRITY
    • CULTURE
    • Education
    • FASHION
    • FOOD
    • HEALTH
    • HISTORY
    • Nature
    • Religion
    • Shopping
    • TRAVEL
  • REAL ESTATE
  • Blog
  • Classifieds
No Result
View All Result
westvirginiadigitalnews.com
No Result
View All Result
Home PRESS RELEASE

U.S. FDA approves first treatment option for generalized pustular psoriasis flares in adults

admin by admin
September 2, 2022
in PRESS RELEASE
0
U.S. FDA approves first treatment option for generalized pustular psoriasis flares in adults
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter


INGELHEIM, Germany–(BUSINESS WIRE)–The U.S. Food and Drug Administration is the first regulatory authority to approve spesolimab as a treatment option for generalized pustular psoriasis (GPP) flares in adults, Boehringer Ingelheim announced today. Spesolimab, marketed in the U.S. as SPEVIGO®, is a novel, selective antibody that blocks the activation of the interleukin-36 receptor (IL-36R), a signaling pathway within the immune system shown to be involved in the pathogenesis of GPP.

“GPP flares can greatly impact a patient’s life and lead to serious, life-threatening complications,” said Mark Lebwohl, M.D., lead investigator and publication author, and Dean for Clinical Therapeutics, Icahn School of Medicine at Mount Sinai, Kimberly and Eric J. Waldman Department of Dermatology, New York. “The approval of spesolimab is a turning point for dermatologists and clinicians. We now have an FDA-approved treatment that may help make a difference for our patients who, until now, have not had any approved options to help manage GPP flares.”

“This important approval reflects our successful efforts to accelerate our research with the aim to bring innovative treatments faster to the people most in need,” said Carinne Brouillon, Member of the Board of Managing Directors, responsible for Human Pharma, Boehringer Ingelheim. “We recognize how devastating this rare skin disease can be for patients, their families and caregivers. GPP can be life-threatening and until today there have been no specific approved therapies for treating the devastating GPP flares. It makes me proud that with the approval of SPEVIGO® we can now offer the first U.S. approved treatment option for those in need.”

The FDA’s approval of spesolimab is based on results from the pivotal EFFISAYIL® 1 Phase II clinical trial.1 In the 12-week trial, patients experiencing a GPP flare were treated with spesolimab or placebo. Most patients at the outset of the trial had a high, or very high, density of pustules, and impaired quality of life. After one week, 54% of patients treated with spesolimab showed no visible pustules compared to placebo (6%).1

In addition to the U.S. approval, spesolimab is currently under review by several other regulatory authorities. To date, spesolimab has received Breakthrough Therapy Designation in the U.S., China and Taiwan, Priority Review in the U.S. and China, Orphan Drug Designation in the U.S., Korea, Switzerland and Australia, Rare Disease Designation and fast track in Taiwan, for the treatment of GPP flares. The European Medicines Agency validated the marketing authorization application for spesolimab in GPP in October 2021 and the submission is currently under evaluation.

Distinct from plaque psoriasis, GPP is a rare and potentially life-threatening neutrophilic skin disease, characterized by episodes of widespread eruptions of painful, sterile pustules. Given that it is so rare, recognizing the symptoms can be challenging and consequently lead to delays in diagnosis.

For the full press release and link tor ‘Notes to Editors’ please click here: https://www.boehringer-ingelheim.com/human-health/skin-diseases/fda-approves-first-gpp-flare-treatment



Source link

RELATED POSTS

Helbiz Provides Transparency on Filed Proxy Statement

Video shows struggle for hammer during Pelosi attack

ShareTweetPin
admin

admin

Related Posts

Helbiz Provides Transparency on Filed Proxy Statement

Helbiz Provides Transparency on Filed Proxy Statement

by admin
January 27, 2023
0

NEW YORK--(BUSINESS WIRE)--Helbiz, Inc. (NASDAQ: HLBZ), a leading global provider of electric shared micro-mobility solutions, announced today that it has...

Video shows struggle for hammer during Pelosi attack

Video shows struggle for hammer during Pelosi attack

by admin
January 27, 2023
0

Video released publicly Friday shows the husband of former U.S. House Speaker Nancy Pelosi fighting with his assailant for control...

American Water’s Unmanned Aerial System Program Enters into Partnership with The New Jersey Innovation Institute

American Water’s Unmanned Aerial System Program Enters into Partnership with The New Jersey Innovation Institute

by admin
January 27, 2023
0

CAMDEN, N.J.--(BUSINESS WIRE)--American Water (NYSE: AWK), the largest publicly traded U.S. water and wastewater utility company, announced today its Unmanned...

Tyre Nichols: Family urges calm ahead of video release – BBC

Tyre Nichols: Family urges calm ahead of video release – BBC

by admin
January 27, 2023
0

Tyre Nichols: Family urges calm ahead of video release  BBC Source link

Lavoro Announces the Acquisition of Cromo Química

Lavoro Announces the Acquisition of Cromo Química

by admin
January 27, 2023
0

SÃO PAULO--(BUSINESS WIRE)--Lavoro, Brazil’s largest agricultural input retailer, continues its expansion in Latin America with the acquisition of a majority...

Next Post
8 Big & Tall Retailers to Bookmark, Now!

8 Big & Tall Retailers to Bookmark, Now!

eLearning Topics To Cover In Your Guest Article [September 2022]

eLearning Topics To Cover In Your Guest Article [September 2022]

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fivver Ads

RECOMMENDED

Helbiz Provides Transparency on Filed Proxy Statement

Helbiz Provides Transparency on Filed Proxy Statement

January 27, 2023
Video shows struggle for hammer during Pelosi attack

Video shows struggle for hammer during Pelosi attack

January 27, 2023
  • 650 Followers
  • 23.7k Followers

MOST VIEWED

  • Oil Rallies With OPEC+ Decision, G-7 Cap Plan Dominating Trading

    Oil Rallies With OPEC+ Decision, G-7 Cap Plan Dominating Trading

    0 shares
    Share 0 Tweet 0
  • Bed Bath & Beyond CFO Gustavo Arnal falls to his death from New York skyscraper

    0 shares
    Share 0 Tweet 0
  • No Escape From Biggest Bond Loss in Decades as Fed Keeps Hiking

    0 shares
    Share 0 Tweet 0
  • Trump wins special master ruling from federal judge over seized documents by FBI

    0 shares
    Share 0 Tweet 0
  • How much does the average Gen Z worker make? Results by state

    0 shares
    Share 0 Tweet 0
westvirginiadigitalnews.com

CATEGORY

  • APPS
  • ARTS & THEATER
  • BUSINESS
  • CELEBRITY
  • CRYPTO
  • CULTURE
  • ECONOMY
  • Education
  • ENTERTAINMENT
  • FASHION
  • FINANCE
  • FOOD
  • GADGET
  • Gambling
  • GAMING
  • HEALTH
  • HISTORY
  • LIFESTYLE
  • MARKET
  • MOBILE
  • MONEY
  • MOVIE
  • MUSIC
  • Nature
  • News
  • PRESS RELEASE
  • REAL ESTATE
  • Religion
  • SCIENCE
  • Shopping
  • SHOWS
  • SPORTS
  • TECH
  • TRAVEL

Helbiz Provides Transparency on Filed Proxy Statement

Video shows struggle for hammer during Pelosi attack

American Water’s Unmanned Aerial System Program Enters into Partnership with The New Jersey Innovation Institute

Tyre Nichols: Family urges calm ahead of video release – BBC

Lavoro Announces the Acquisition of Cromo Química

Bed Bath & Beyond makes desperate move while teetering toward bankruptcy: Source

Warner Bros. swiped our Harry Potter wand IP, says Kano • TechCrunch

Season 2 Confirmed & More To Know – Hollywood Life

Winter Activities | Cup of Jo

Biden’s “Renters Bill of Rights” Is Here — Is Nationwide Rent Control Coming?

Is Rob Gronkowski serious about returning to the NFL?

Kourtney Kardashian Addresses Backlash Over Boohoo Collaboration

How to get US apps on a UK account

Salami Sandwich | The Recipe Critic

Tesla’s battery supplier in China is hanging by a thread, with a ‘factory bubble’ the only way it’s still working

Fed Chair Jerome Powell Updates Work on Digital Dollar — Says US Central Bank Digital Currency Will Take ‘at Least a Couple of Years’ – Regulation Bitcoin News

Дым — Smoke [Mime theatre ILINASTROE]

Batch Record Review and Product Release Virtual Seminar – ResearchAndMarkets.com

Song Exploder – Rick Astley

Links 10/16/2022

  • Disclaimer
  • Privacy Policy
  • Copyright Notice
  • Anti Spam Policy
  • Medical Disclaimer
  • DMCA Compliance
  • Terms and Conditions
  • Social Media Disclaimer
  • Amazon Affiliate disclaimer

© 2022 Westvirginiadigitalnews.com

No Result
View All Result
  • Home
  • News
    • PRESS RELEASE
  • Shop
  • BUSINESS
    • CRYPTO
    • ECONOMY
    • FINANCE
    • MARKET
    • MONEY
  • TECH
    • APPS
    • GADGET
    • MOBILE
    • SCIENCE
  • SOCIAL MEDIA
  • ENTERTAINMENT
    • ARTS & THEATER
    • GAMING
    • GAMBLING
    • MOVIE
    • MUSIC
    • SHOWS
    • SPORTS
  • LIFESTYLE
    • CELEBRITY
    • CULTURE
    • Education
    • FASHION
    • FOOD
    • HEALTH
    • HISTORY
    • Nature
    • Religion
    • Shopping
    • TRAVEL
  • REAL ESTATE
  • Blog
  • Classifieds

© 2022 Westvirginiadigitalnews.com